Introducing preventive management of chronic thyroid conditions through patient empowerment and a ML-powered mHealth solution

Informazioni relative al progetto

BOOST HEALTH

ID dell’accordo di sovvenzione: 864004

DOI

10.3030/864004

Progetto chiuso

Data della firma CE 26 Aprile 2019

Data di avvio 1 Maggio 2019

Data di completamento 31 Ottobre 2019

Finanziato da

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Costo totale

€ 71 429,00

Contributo UE

€ 50 000,00

Coordinato da

VLM HEALTH UG
Germany

Periodic Reporting for period 1 - BOOST HEALTH (Introducing preventive management of chronic thyroid conditions through patient empowerment and a ML-powered mHealth solution)

Periodo di rendicontazione: 2019-05-01 al 2019-10-31

Sintesi del contesto e degli obiettivi generali del progetto

Chronic autoimmune conditions affect 800 million people and cost €400bn a year because of too-late diagnosis and the absence of prevention. The best way to minimize the effect is by creating positive lifestyle habits, improving conversations with doctors, and increasing knowledge through collaboration with biomedical research.

Autoimmune conditions are predominantly female, and as such did not get appropriate research and medical attention. We can solve this by utilising digital technologies to collect Big Data and bring more knowledge to the general public.

Overall objectives of the feasibility phase were:
1. Empowering patients through regularly analysis of their health and well-being
2. Validation in clinical setting
3. Developing a prototype on how will the ML-assisted health plan look like

Lavoro eseguito dall’inizio del progetto fino alla fine del periodo coperto dalla relazione e principali risultati finora ottenuti

"Main results are:

1. New and improved app features – a) symptom analytics, b) new ""home screen"" with expanded overview of symptoms, lab tests and informational texts; and c) Exportable PDF of doctor report
2. Analysis of benefit for patients, as presented on the 89th American Thyroid Association yearly congress - patients reported that the information obtained through the app is more helpful than going to the doctors office\
3. Early prototype of ML-delivered benefit to the patient"

Progressi oltre lo stato dell’arte e potenziale impatto previsto (incluso l’impatto socioeconomico e le implicazioni sociali più ampie del progetto fino ad ora)

"We are continuing the project, and building the next stage of our service:
1. providing a better connection between patients and doctors
2. working on covering health complications (starting with fertility) and
3. partnering with healthcare businesses in order to start the revenue stream


We expect our impact will be measured in:
1. increased awareness and early diagnosis of the thyroid conditions
2. early detection of health complications
3. development of more individualised therapies


Increasing awareness, which was achieved in the so far project has had a tremendous impact on BOOST Thyroid app users. People using our solution told us that information we provide helped them stay healthier, that sharing common experiences through our ""Hashi and me"" stories helped them not feel alone, isolated and not understood."

BOOST Thyroid app